chr16-55661194-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001172501.3(SLC6A2):c.274+4226C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0879 in 152,238 control chromosomes in the GnomAD database, including 653 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.088 ( 653 hom., cov: 33)
Consequence
SLC6A2
NM_001172501.3 intron
NM_001172501.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.351
Publications
34 publications found
Genes affected
SLC6A2 (HGNC:11048): (solute carrier family 6 member 2) This gene encodes a member of the sodium:neurotransmitter symporter family. This member is a multi-pass membrane protein, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis. Mutations in this gene cause orthostatic intolerance, a syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
SLC6A2 Gene-Disease associations (from GenCC):
- postural orthostatic tachycardia syndromeInheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.157 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC6A2 | NM_001172501.3 | c.274+4226C>T | intron_variant | Intron 2 of 14 | ENST00000568943.6 | NP_001165972.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0880 AC: 13390AN: 152120Hom.: 656 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
13390
AN:
152120
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0879 AC: 13388AN: 152238Hom.: 653 Cov.: 33 AF XY: 0.0904 AC XY: 6726AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
13388
AN:
152238
Hom.:
Cov.:
33
AF XY:
AC XY:
6726
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
1678
AN:
41562
American (AMR)
AF:
AC:
1729
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
283
AN:
3472
East Asian (EAS)
AF:
AC:
725
AN:
5168
South Asian (SAS)
AF:
AC:
804
AN:
4820
European-Finnish (FIN)
AF:
AC:
1169
AN:
10606
Middle Eastern (MID)
AF:
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6647
AN:
67992
Other (OTH)
AF:
AC:
170
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
628
1256
1885
2513
3141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
571
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.